🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Faisal Khurshid

Stock Analyst at Jefferies

(4.98)
# 54
Out of 5,184 analysts
254
Total ratings
60.6%
Success rate
65%
Average return

Stocks Rated by Faisal Khurshid

Lycia Therapeutics
Nov 17, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $33.07
Upside: +51.19%
Yarrow Bioscience
Nov 15, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $12.90
Upside: +210.08%
Monte Rosa Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $25 → $15
Current: $8.64
Upside: +73.61%
Alnylam Pharmaceuticals
Oct 29, 2026
Reiterated: Hold
Price Target: $260 → $250
Current: $143.82
Upside: +73.83%
EyePoint
Oct 19, 2026
Downgraded: Hold
Price Target: $8 → $1
Current: $0.2342
Upside: +326.99%
Vicore Pharma Holding AB
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $9.41
Upside: +165.81%
Summit Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.95
Upside: -
Revolution Medicines
Sep 3, 2026
Reiterated: Buy
Price Target: $270
Current: $161.20
Upside: +67.49%
Ascendis Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $290 → $330
Current: $252.73
Upside: +30.57%
Immatics
Aug 25, 2026
Rated: Buy
Price Target: $18 → $17
Current: $5.77
Upside: +194.63%
Reiterated: Buy
Price Target: $160 → $175
Current: $141.33
Upside: +23.82%
Upgraded: Buy
Price Target: $333 → $380
Current: $390.94
Upside: -2.80%
Upgraded: Buy
Price Target: $90 → $158
Current: $73.20
Upside: +115.85%
Reiterated: Buy
Price Target: $29 → $30
Current: $29.96
Upside: +0.13%
Reiterated: Buy
Price Target: $15 → $8
Current: $6.33
Upside: +26.38%
Upgraded: Buy
Price Target: $76 → $85
Current: $56.42
Upside: +50.66%
Reiterated: Buy
Price Target: $40 → $37
Current: $8.72
Upside: +324.31%
Initiated Coverage: Buy
Price Target: $21
Current: $10.23
Upside: +105.28%
Reiterated: Buy
Price Target: $103 → $120
Current: $68.55
Upside: +75.05%
Initiated Coverage: Buy
Price Target: $55
Current: $26.72
Upside: +105.88%
Initiated Coverage: Buy
Price Target: $15
Current: $9.02
Upside: +66.30%
Downgraded: Hold
Price Target: $33
Current: $26.41
Upside: +24.95%
Downgraded: Hold
Price Target: $94
Current: $114.63
Upside: -17.99%
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $115.31
Upside: -4.60%
Reiterated: Buy
Price Target: $20 → $21
Current: $8.68
Upside: +141.94%
Reiterated: Buy
Price Target: $142
Current: $112.36
Upside: +26.38%
Downgraded: Hold
Price Target: $5 → $4
Current: $9.69
Upside: n/a
Reiterated: Hold
Price Target: $12
Current: $12.85
Upside: n/a
Upgraded: Buy
Price Target: $29 → $40
Current: $33.31
Upside: n/a
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.85
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $3.82
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $14.93
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $0.9305
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $13.35
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $6.99
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $121.40
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $93.47
Upside: n/a
Reiterated: Buy
Price Target: $4 → $2
Current: $4.46
Upside: n/a
Reiterated: Buy
Price Target: $3
Current: $0.8707
Upside: n/a
Reiterated: Hold
Price Target: $1
Current: $4.70
Upside: n/a
Reiterated: Hold
Price Target: $2
Current: $0.5951
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $84.92
Upside: n/a